Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ROL stock price vs PG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PG's multiple
Needs PG P/E.
Implied fair value · at ROL's multiple
Needs ROL P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROLLINS, INC. · implied price per share
Bear
$14.27
Base
$16.97
Bull
$20.49
The Procter & Gamble Company · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ECOLAB INC.
ROL vs ECL
HOME DEPOT, INC.
ROL vs HD
Serve Robotics Inc. /DE/
ROL vs SERV
CINTAS CORP
ROL vs CTAS
IRON MOUNTAIN INC
ROL vs IRM
MAXIMUS, INC.
ROL vs MMS
COLGATE PALMOLIVE CO
ROL vs CL
KIMBERLY CLARK CORP
ROL vs KMB
CHURCH & DWIGHT CO INC /DE/
ROL vs CHD
CLOROX CO /DE/
ROL vs CLX
Johnson & Johnson
ROL vs JNJ
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ROL can sustain 11.0% revenue growth and preserve its high ROIC, then hold or add selectively despite the premium valuation because the balance sheet is strong and growth is materially better than PG; if growth normalizes, the current 34.8x P/E leaves limited upside.
ROL trades at a rich valuation versus PG on both earnings and sales, and the provided P/E-based implied price of $24.19 suggests meaningful downside from the current $37.97 share price. However, ROL’s higher growth and stronger leverage profile help explain why it can sustain a premium to PG despite the negative spread.
Supporting Metrics
